Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Azathioprine and prednisolone reduce relapse rates in neuromyelitis optica

Nov. 3, 2010

Mild toxicity and disease stabilizations seen with L19TNF-alpha in patients with cancer

Nov. 2, 2010

Effects of denosumab reported in patients with prostate cancer and bone metastases

Nov. 2, 2010

Clinical trials explore efficacy of budesonide in treating eosinophilic esophagitis

Nov. 2, 2010

Data from several studies on mitoxantrone for relapsing-remitting MS made available

Nov. 2, 2010

Rifaximin-EIR induces durable remissions in patients with Crohn's disease

Oct. 29, 2010

BETAPEDIC trial of IFN-beta-1b in juvenile patients with MS is enrolling participants

Oct. 29, 2010

AR-452530 and AR-460770 reduce symptoms of EAE in vivo

Oct. 29, 2010

Combination of WX-671 and gemcitabine shows promise in phase II trial in pancreatic cancer

Oct. 29, 2010

Fampridine therapy increases walking speed of patients with MS in phase II/III trials

Oct. 29, 2010

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...